THE WHAT? The U.S. congress has introduced a new bill that will approve CBD for use in dietary supplements, a move that aims to push the FDA into approving the ingredient, according to Natural Products Insider.
THE DETAILS With the FDA accused of dragging its feet in the approval of the ingredient, the new Hemp and Hemp-Derived CBD Consumer Protection and Market Stabilization Act of 2021 bill (H.R. 841) is identical to the H.R. 8179 introduced last congress.
The bill will approve CBD as well as all the other cannabinoids and terpenes within hemp, and was introduced by Democrat Kurt Schrader and Republican Morgan Griffith, alongside five Republican and 12 Democratic co-sponsors.
Maintaining hemp’s definition of a cannabis plant with less than 0.3% THC, the bill will make hemp subject to the same regulations as other dietary supplements
THE WHY? The move follows what industry insiders have called ‘inaction’ by the FDA to approve the ingredient, with Julia Gustafson, Vice President of government relations for Council for Responsible Nutrition (CRN), stating, “Due to continued FDA inaction more consumers are at risk every day of unsafe or illegal products that are poorly manufactured, incorrectly labeled, or illegally deliver THC or other adulterants.”
The move by Congress is hoped to enforce the FDA to act, with the CRN stating, “We call on FDA to constructively engage with the bill sponsors and other stakeholders to address any reservations it may have and to help craft legislation that protects public health while fostering a new category of supplements.”
A coalition of 18 groups support the new bill.